Colostrum Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Form (Powder, Capsule and Chewable Tablets), By Powder Type (Whole Colostrum Powder, Skimmed Colostrum Powder, Speciality Colostrum Powder), By Application (Functional Foods, Infant Foods, Cosmetics, Animal Feed, Dietary Supplements), And Geography - Forecasts From 2023 To 2028

The colostrum market is evaluated at US$1,108.443 million for the year 2021 and is projected to grow at a CAGR of 5.57% to reach a market size of US$1,620.414 million by the year 2028.

Colostrum is a bovine-derived nutritional supplement that contains a variety of bioactive proteins and other components that help to maintain lean muscle tissue and a healthy immune system. Because of the presence of IgG antibodies, it is considered one of nature's superfoods. It most likely aids in the bioavailability and nutrient absorption into the body, as well as gastrointestinal wellness. Colostrum coats the stomach and intestines of the baby, preventing bacteria from causing disease. For adults with particular sensitivities, bovine proteins in colostrum are identical to whey or casein.

Development factors found in colostrum aid cell repair and growth. As a result, some premium skincare products use colostrum as an ingredient to help protect against environmental impacts. Colostrum also helps to relieve skin irritation and aids in the treatment of skin problems. It has antimicrobial properties as well as a hydrating effect on the skin. Colostrum cosmetics improve skin elasticity and resistance, slow down the ageing process, and brighten the skin on the face. For example, Viveza Holding's MCE Pharma brand offers a whole line of high-end cosmetics, as well as related items in a more affordable price range. Colostrum is high in antibodies and has been shown to boost immunity. As a result, it is becoming more popular as the trend of ingesting healthy items catches on. There's also a bigger focus on sustainability and certifications, as well as enhanced openness and traceability of the ingredients. These are some of the primary market drivers for colostrum.

The market for colostrum-based infant formula is increasing both in advanced economies and in emerging nations since bovine colostrum has better nutritional value than human colostrum. Colostrum is easily digestible by babies, prompting more colostrum manufacturers to create colostrum-based infant formulae. It defends an infant's gastrointestinal tract by preventing pathogens from entering. It creates more IgG antibodies, which aid in the development of the baby's immune system. Colostrum contains immunoglobulin, which increases an infant's immunity and makes it easier for them to absorb nutrients. Another reason for the high demand for colostrum-based newborn food is the growing middle-class population, which is causing colostrum-based infant formula products to become more widely available in worldwide markets.

Because of its widespread availability, the whole colostrum powder segment has the largest market share. Furthermore, the sector of tablets and capsules is expected to grow at the fastest rate during the projection period. Since there are no added components outside of natural colostrum, the product has a long shelf life. Whole colostrum powder is commonly supplemented with natural substances including medium-chain triglycerides and sunflower lecithin, which improves its solubility and flow.  Whole colostrum powder has a high creaminess, making it an excellent addition to smoothies and drinks, or it can be dissolved in water and drunk straight. The substance has several advantages, including gut healing, immunological support, digestive health, and improved workout recovery. Whole colostrum powder is less expensive than other colostrum preparations because it is gathered soon after calving, preserving nutrients and reducing the risk of contamination.

The highest contributing segment to the global colostrum market in North America. With the current advancements, the demand for more supplements to meet the expanding demands of customers in the North American region has been met to some extent. Unhealthy food habits have been a source of worry for the local populace and, as a result, a direct platform for manufacturers to conduct R&D. Because of their poor eating habits, the people of the United States have realized that it is more necessary to immunize themselves beforehand than to suffer future issues.

COVID-19 Impact on the Colostrum Market

The COVID-19 outbreak caused substantial supply chain delays, technology event cancellations, production plant shutdowns, and other issues in the food and beverage industry. The suspension of various plant and factory operations in key regions has a detrimental influence on global supply chains, manufacturing, delivery schedules, and good sales. Furthermore, travel prohibitions enforced by countries in Europe, Asia, and North America are harming prospects for corporate collaboration and partnerships. These reasons are impeding the food and beverage industry's growth, as well as the growth of numerous linked markets, such as the colostrum market.

Recent Development

In March 2021, PanTheryx, a leader in nutrition and biotechnology, announced the debut of three bovine colostrum-based product formulations: soft chews, baked nutrition bars, and soft presses. In May 2021, Tallink Group’s Estonian boats began offering Bio  Block, a new nasal spray containing antibodies against the SARS-CoV-2 virus obtained from cattle.

Colostrum Market Scope:

 

Report Metric	Details
Market Size Value in 2021	US$1,108.443 million
Market Size Value in 2028	US$1,620.414 million
Growth Rate	CAGR of 5.57% from 2021 to 2028
Base Year	2021
Forecast Period	2023 – 2028
Forecast Unit (Value)	USD Million
Segments Covered	Form, Powder Type, Application, And Geography
Regions Covered	North America, South America, Europe, Middle East and Africa, Asia Pacific
Companies Covered	NOW Foods, The Saskatoon Colostrum Company, Good Health, Sterling Technology, Colostrum BioTec GmbH, Zuche Pharmaceuticals, Agati Healthcare Pvt. Ltd., McePharma, Cure Nutraceuticals Pvt. Ltd., Ingredia Nutritional, Biotaris B.V., La Belle Inc.
Customization Scope	Free report customization with purchase

 

Market Segmentation

• By Form
  • Powder
  • Capsule and Chewable tablets
• By Powder type
  • Whole Colostrum Powder
  • Skimmed Colostrum Powder
  • Speciality Colostrum Powder
• By Application
  • Functional foods
  • Infant foods
  • Cosmetics
  • Animal feed
  • Dietary supplements
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • Israel
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Taiwan
    • Others

---

1. Introduction
1.1. Market Definition
1.2. Market Segmentation

2. Research Methodology
2.1. Research Data
2.2. Assumptions

3. Executive Summary
3.1. Research Highlights

4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of End-Users
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. Colostrum Market Analysis, by Form
5.1. Introduction 
5.2. Water-based
5.3. Solvent-based
5.4. Hot-melt
5.5. Reactive
5.6. Other

6. Colostrum Market Analysis, by Powder type
6.1. Introduction
6.2.  Whole Colostrum Powder
6.3. Skimmed Colostrum Powder
6.4. Speciality Colostrum Powder

7. Colostrum Market Analysis, by Application
7.1. Introduction
7.2.  Functional foods
7.3. Cosmetics
7.4. Infant foods
7.5. Animal feed
7.6. Dietary supplements

8. Colostrum Market Analysis, by Geography
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Others
8.5. The Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. Israel
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Taiwan
8.6.8. Others 

9. Competitive Environment and Analysis
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix

10. Company Profiles 
10.1. NOW Foods
10.2. The Saskatoon Colostrum Company
10.3. Good Health 
10.4. Sterling Technology.
10.5. Colostrum BioTec GmbH
10.6. Zuche Pharmaceuticals 
10.7. Agati Healthcare Pvt. Ltd.
10.8. McePharma
10.9. Cure Nutraceuticals Pvt. Ltd.
10.10. Ingredia Nutritional
10.11. Biotaris B.V.
10.12. La Belle Inc.

NOW Foods

The Saskatoon Colostrum Company

Good Health

Sterling Technology.

Colostrum BioTec GmbH

Zuche Pharmaceuticals

Agati Healthcare Pvt. Ltd.

McePharma

Cure Nutraceuticals Pvt. Ltd.

Ingredia Nutritional

Biotaris B.V.

La Belle Inc.